← Leaderboards
Christopher D. Heinen
University Of Connecticut Sch Of Med/Dnt
$5,919,532
Attributed
$6,130,374
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,130,374 · 5
By mechanism
R01$5,367,356 · 3
R21$763,018 · 2
Top collaborators
- Justin Lee Cotney2 shared
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Blanka Rogina$6,290,467
Others in their field
Top investigators on “Endometrial”
- Philip J Disaia · University Of California Irvine$151,852,944
- David Heimbrook · Leidos Biomedical Research, Inc.$57,537,613
- Walter John Curran · Thomas Jefferson University$51,956,876
- Norman Wolmark · Nsabp Foundation, Inc.$25,315,327
- Leslie Bernstein · University Of Southern California$21,004,851
- Linda C Giudice · Stanford University$17,025,878
Research focus
EndometrialColorectalOvarianMalignant NeoplasmsColorectal CancerCellsAffectMutationInheritedHereditary Nonpolyposis Colorectal NeoplasmsGenesMismatch RepairResponsePathway InteractionsMlh1 GeneDna DamagePhenotypeDefectApoptosisMediatingBiochemicalCessation Of LifeIn VitroHereditary Disease
Grant awards (21)
The selective advantage of mismatch repair loss in colonic stem cells$401,731
R01 · FY2025 · CA · contact PI
The selective advantage of mismatch repair loss in colonic stem cells$423,202
R01 · FY2024 · CA · contact PI
Hereditary Cancer Variants of Uncertain Significance in Stem Cells$231,494
R01 · FY2024 · CA · contact PI
The selective advantage of mismatch repair loss in colonic stem cells$468,099
R01 · FY2023 · CA · contact PI
Hereditary Cancer Variants of Uncertain Significance in Stem Cells$354,348
R01 · FY2023 · CA · contact PI
The selective advantage of mismatch repair loss in colonic stem cells$471,589
R01 · FY2022 · CA · contact PI
Hereditary Cancer Variants of Uncertain Significance in Stem Cells$96,922
R01 · FY2022 · CA · contact PI
The selective advantage of mismatch repair loss in colonic stem cells$488,887
R01 · FY2021 · CA · contact PI
Hereditary Cancer Variants of Uncertain Significance in Stem Cells$402,702
R01 · FY2021 · CA · contact PI
Saturation genome editing approach to functionally test all possible MSH2 variants$191,675
R21 · FY2021 · CA · contact PI
Hereditary Cancer Variants of Uncertain Significance in Stem Cells$375,150
R01 · FY2020 · CA · contact PI
Saturation genome editing approach to functionally test all possible MSH2 variants$230,010
R21 · FY2020 · CA · contact PI
Hereditary Cancer Variants of Uncertain Significance in Stem Cells$71,425
R01 · FY2020 · CA · contact PI
Hereditary Cancer Variants of Uncertain Significance in Stem Cells$374,293
R01 · FY2019 · CA · contact PI
Pluripotent stem cells as a novel model to test hereditary cancer variants$170,884
R21 · FY2015 · CA · contact PI
Pluripotent stem cells as a novel model to test hereditary cancer variants$170,449
R21 · FY2014 · CA · contact PI
Mismatch Repair Functions Affected During Tumorigenesis$238,310
R01 · FY2012 · CA · contact PI
Mismatch Repair Functions Affected During Tumorigenesis$237,343
R01 · FY2011 · CA · contact PI
Mismatch Repair Functions Affected During Tumorigenesis$244,485
R01 · FY2010 · CA · contact PI
Mismatch Repair Functions Affected During Tumorigenesis$245,680
R01 · FY2009 · CA · contact PI
Mismatch Repair Functions Affected During Tumorigenesis$241,696
R01 · FY2008 · CA · contact PI